Brain Medicine
Breakthroughs in Gene Therapy For Anxiety & Other Neuropsychiatric Disorders
$32.76
- Paperback
180 pages
- Release Date
23 June 2026
Summary
BREAKTHROUGH GENE THERAPY FOR ANXIETY TREATMENT
With more than 30 percent of Americans experiencing anxiety disorders at some point in their lives—and with treatment costs continuing to rise—there is growing demand for innovative solutions that address anxiety at its biological roots.
In Brain Medicine, neuroscientist Troy Rohn, PhD, presents a bold and hopeful vision for the future of anxiety treatment. Blending cutting-edge neurological research with his own lived…
Book Details
| ISBN-13: | 9781961293663 |
|---|---|
| ISBN-10: | 1961293668 |
| Author: | Troy Rohn, Dean Radin |
| Publisher: | Hatherleigh Press,U.S. |
| Imprint: | Hatherleigh Press,U.S. |
| Format: | Paperback |
| Number of Pages: | 180 |
| Release Date: | 23 June 2026 |
| Weight: | 369g |
| Dimensions: | 152mm x 228mm |

You Can Find This Book In
Critics Review
“A confident, readable breakdown of the current state of therapeutic gene therapy.”
—Kirkus Reviews
“Finally, a book that establishes how the nervous system and psychology come together. Want to understand how far the medical field has come in treating anxiety and similar conditions? Start here.”
—Noail Isho, MD, neurologist
“…offers a hopeful yet honest assessment of the exciting potential of gene therapy for the treatment of neuropsychiatric disease.”
—Ben Sachs, Professor of Neuroscience, Villanova University
“There is no better narrator to convey the complexities of the human mind and the intricacies of experimental design in the modern era of drug development.”
—Ryan Holzer, Ph.D., founder and director, Rosetta Institute of Biomedical Research
“…guides us through the wonders of modern science and the possibilities of personalized gene therapy through sharing his lived experience of anxiety.”
—Ryan Day, MD, primary care internal medicine physician
“A thoughtful and rigorously grounded contribution to the neuroscience of anxiety and neuropsychiatric disorders, integrating empirical research with clinically informed insight.”
—Jamison Lee, Ph.D. candidate in Neuropsychiatry Disorders
“A compelling read that details the use of cutting-edge molecular biology to improve the lives of millions who live with debilitating anxiety.”
—Tara Rothwell, PA-C, MS, MPAS
Troy Rohn
Troy Rohn, PhD, has built a substantial academic reputation with nearly three decades of experience in neuroscience research and teaching. For his contributions to Alzheimer’s research and neurological disorders, he was recently recognized as one of the top 0.5% of scholars worldwide. Dr. Rohn received his Ph.D. in Pharmacology from the University of Washington, Seattle. He had several Postdoctoral stints including 2+ years living in France, a year at Montana State University, and 2 years at UC Irvine. He has obtained extramural funding continuously since his arrival at Boise State University (where he currently works as a professor in the Biology Department) including grants from NIH, AFAR, and AHAF. Dr. Rohn has authored over 80 peer-reviewed publications, many of which address topics related to neurobiology, mental health, and treatment strategies.
Dean Radin, PhD, currently serves as Chief Scientist at the Institute of Noetic Sciences (IONS) and Associated Distinguished Professor at the California Institute of Integral Studies. His academic background includes a PhD in psychology from the University of Illinois, Urbana-Champaign. Before joining IONS in 2001, he worked on advanced research and development at AT&T Bell Labs and GTE Laboratories. With Dr. Rohn, Dr. Radin is the co-founder and Vice Chairman of Cognigenics, a research group working to pioneer non-invasive genetic medicine for the brain. He is also the author/co-author of hundreds of articles and several popular books, including The Conscious Universe and Entangled Minds.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.



